Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

GE HealthCare to Acquire Sofie Biosciences

5 October 2026 · By · Wire by Fusion42

Published

5 October 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at mddionline.com →

◆ Verified

Fusion42 · 5 October 2026 · Fusion42 review

GE HealthCare is acquiring Sofie Biosciences for $945 million to expand its capabilities in radiopharmaceuticals.

This Wire brief sits within Fusion42's coverage of Medtech, and 4 sources have reported it between 5 Oct 2026 and 6 Oct 2026.

◆ ◆ The Wire takeaway

You now have a clear signal that radiopharmaceuticals are attracting large strategic investment and entering a growth phase. If you're building in Medtech imaging or drug delivery, this is a door to push on for business development and technology partnerships.

◆ Coverage

4 sources · first reported 5 Oct 2026 · latest 6 Oct 2026

◆ Related on Wire

◆ Topics

Medtechm-aradiopharmaceuticalshealthcaremedtechinnovation